Karo Bio granted Alkem exclusive commercialization rights to eprotirome in India and other undisclosed Asia-Pacific and African countries

Karo Bio AB

Sweden / Small-Cap Biopharma (<$1 billion)

$106.8m on 02/04/2011 [market cap]

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Alkem Laboratories Ltd.

India / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced